Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley C Jordan

Showing results (31-40 of 191) with videos related to

Pageof 20
Sort By:
Current Opinion in Organ Transplantation|December 13, 2023
Advances in desensitization for human leukocyte antigen incompatible kidney transplantationAshley Vo, Noriko Ammerman, Stanley C Jordan
Clinical Transplants|May 18, 2017
Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials ProcessStanley C Jordan, Jua Choi, Ashley Vo
Immunotherapy|April 29, 2015
Achieving incompatible transplantation through desensitization: current perspectives and future directionsStanley C Jordan, Jua Choi, Ashley Vo
British Medical Bulletin|May 4, 2015
Kidney transplantation in highly sensitized patientsStanley C Jordan, Jua Choi, Ashley Vo
Kidney360|July 12, 2024
New Therapies for Highly Sensitized Patients on the Waiting ListAshley Vo, Noriko Ammerman, Stanley C Jordan
Expert Review of Clinical Immunology|May 21, 2011
Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantationStanley C Jordan, Mieko Toyoda, Ashley A Vo
Contributions to Nephrology|November 13, 2008
Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipientsStanley C Jordan, Alice Peng, Ashley A Vo
Transplantation|November 25, 2015
Potential Roles for C1 Inhibitor in TransplantationMel Berger, William M Baldwin, Stanley C Jordan
Expert Review of Clinical Immunology|October 29, 2010
ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?Joseph Kahwaji, Ashley A Vo, Stanley C Jordan
Transplantation|July 9, 2009
Intravenous immunoglobulin a natural regulator of immunity and inflammationStanley C Jordan, Mieko Toyoda, Ashley A Vo
Pageof 20

Showing results (31-40 of 191) with videos related to

Sort By:
Pageof 20
Current Opinion in Organ Transplantation|December 13, 2023
Advances in desensitization for human leukocyte antigen incompatible kidney transplantationAshley Vo, Noriko Ammerman, Stanley C Jordan
Clinical Transplants|May 18, 2017
Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials ProcessStanley C Jordan, Jua Choi, Ashley Vo
Immunotherapy|April 29, 2015
Achieving incompatible transplantation through desensitization: current perspectives and future directionsStanley C Jordan, Jua Choi, Ashley Vo
British Medical Bulletin|May 4, 2015
Kidney transplantation in highly sensitized patientsStanley C Jordan, Jua Choi, Ashley Vo
Kidney360|July 12, 2024
New Therapies for Highly Sensitized Patients on the Waiting ListAshley Vo, Noriko Ammerman, Stanley C Jordan
Expert Review of Clinical Immunology|May 21, 2011
Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantationStanley C Jordan, Mieko Toyoda, Ashley A Vo
Contributions to Nephrology|November 13, 2008
Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipientsStanley C Jordan, Alice Peng, Ashley A Vo
Transplantation|November 25, 2015
Potential Roles for C1 Inhibitor in TransplantationMel Berger, William M Baldwin, Stanley C Jordan
Expert Review of Clinical Immunology|October 29, 2010
ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?Joseph Kahwaji, Ashley A Vo, Stanley C Jordan
Transplantation|July 9, 2009
Intravenous immunoglobulin a natural regulator of immunity and inflammationStanley C Jordan, Mieko Toyoda, Ashley A Vo
Pageof 20